Literature DB >> 6950396

High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice.

N Hopkins, P Besmer, A B DeLeo, L W Law.   

Abstract

We transformed BALB/3T3 mouse cells with cellular DNA extracted from the Meth A sarcoma, a 3-methylcholanthrene-induced tumor of BALB/c mice, and asked whether foci arising in the transfection possess the previously defined Meth A tumor-specific transplantation antigen (TSTA). Five of eight foci selected from one experiment possessed Meth A TSTA. DNA extracted from one of the five TSTA-positive clones was used in secondary rounds of transfection transformation. Four out of five foci tested from the secondary transfections possessed Meth A TSTA. These results suggest that in the Meth A sarcoma a transforming gene and a genetic determinant of TSTA are intimately related: they may be identical or very closely linked; alternatively, a particular transforming gene might induce the expression of a particular TSTA. Another possible explanation for these results is that the cotransfer of certain cellular genes by DNA transfection is considerably higher than predicted from the limited studies presently available.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6950396      PMCID: PMC349307          DOI: 10.1073/pnas.78.12.7555

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses.

Authors:  I C Henderson; M M Lieber; G J Todaro
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

4.  Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells.

Authors:  S Kit; T Kurimura; D R Dubbs
Journal:  Int J Cancer       Date:  1969-07-15       Impact factor: 7.396

5.  Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors.

Authors:  H Borberg; H F Oettgen; K Choudry; E J Beattie
Journal:  Int J Cancer       Date:  1972-11       Impact factor: 7.396

6.  Identification of DNA fragments carrying ecotropic proviruses of AKR mice.

Authors:  D Steffen; S Bird; W P Rowe; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

8.  Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.

Authors:  L W Law
Journal:  Int J Cancer       Date:  1980-02-15       Impact factor: 7.396

9.  A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection.

Authors:  P Andersson; M P Goldfarb; R A Weinberg
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

10.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  21 in total

1.  The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.

Authors:  T Murakami; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Interference established in mice by infection with Friend murine leukemia virus.

Authors:  T Mitchell; R Risser
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  The role of envelope glycoprotein processing in murine leukemia virus infection.

Authors:  E O Freed; R Risser
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  Viral integration near c-myc in 10-20% of mcf 247-induced AKR lymphomas.

Authors:  Y Li; C A Holland; J W Hartley; N Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

Review 5.  Generation of TSTA diversity. Looking for testable hypotheses.

Authors:  G Parmiani; M A Pierotti
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 6.  Modulation of antitumor immunity--immunobiologic approaches.

Authors:  R J North; E S Dye; C D Mills; J P Chandler
Journal:  Springer Semin Immunopathol       Date:  1982

7.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

8.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  Increased hematopoiesis in mice soon after infection by Friend murine leukemia virus.

Authors:  T Mitchell
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Transfer of sensitivity to tumor promoters by transfection of DNA from sensitive into insensitive mouse JB6 epidermal cells.

Authors:  N H Colburn; C B Talmadge; T D Gindhart
Journal:  Mol Cell Biol       Date:  1983-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.